Citeline Podcasts
By Norstella
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Norstella
Category: Business
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 60
Reviews: 0
Episodes: 509
Description
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
| Episode | Date |
|---|---|
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 6, 2026
|
Apr 06, 2026 |
|
Scrip's Five Must-Know Things - Apr. 6, 2026
|
Apr 06, 2026 |
|
China Biopharma English-Language Podcast: China’s Regulatory Changes In Cell Therapy
|
Apr 03, 2026 |
|
Five-Minute Podcast: “UK Needs To Align More With The EU”
|
Mar 30, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 30, 2026
|
Mar 30, 2026 |
|
Why Longevity Is The Next Big OTC Opportunity, With Euromonitor’s Magda Starula
|
Mar 30, 2026 |
|
Scrip's Five Must-Know Things - Mar.30, 2026
|
Mar 30, 2026 |
|
Drug Fix: US FDA Commissioner Martin Makary Completes First Year In Charge
|
Mar 27, 2026 |
|
Lupin’s CEO And MD On GLP-1 Strategy, Business Growth And Legacy
|
Mar 26, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.23, 2026
|
Mar 23, 2026 |
|
Scrip's Five Must-Know Things - Mar.23, 2026
|
Mar 23, 2026 |
|
Drug Fix: ACIP Next Steps After Judge Stops Work, Potential Opioid Disposal Changes
|
Mar 20, 2026 |
|
How a CDMO Created a Custom Vaccine Development Project
|
Mar 19, 2026 |
|
뇌질환 신약 개발 펀딩 부활 조짐 (Korean-language podcast) Mar.19, 2026
|
Mar 19, 2026 |
|
The Generics Bulletin Podcast: 2026 Conferences
|
Mar 17, 2026 |
|
Winning In The Probiotics Space, With David Pineda Ereño
|
Mar 16, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.16, 2026
|
Mar 16, 2026 |
|
Scrip's Five Must-Know Things - Mar.16, 2026
|
Mar 16, 2026 |
|
Drug Fix: US FDA’s Prasad Leaves, Harry Potter, And Is CNPV Effective Because Of RTOR?
|
Mar 13, 2026 |
|
Killing Cancer Loudly: Onchilles Pharma's Neutrophil-Derived Path to Pan-Cancer Therapy
|
Mar 11, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.9, 2026
|
Mar 09, 2026 |
|
Scrip's Five Must-Know Things - Mar.9, 2026
|
Mar 09, 2026 |
|
Drug Fix: The State Of Facility Inspections With Two Former Senior US FDA Execs
|
Mar 06, 2026 |
|
Unpacking Europe’s Probiotic Rules with David Pineda Ereño
|
Mar 02, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 2, 2026
|
Mar 02, 2026 |
|
Scrip's Five Must-Know Things - Mar.2, 2026
|
Mar 02, 2026 |
|
Drug Fix: State Of The Generics Industry, US FDA Commissioner On Compassionate Use
|
Feb 27, 2026 |
|
Affibody and the Case for Antibody Mimetics in Radioligand Therapy
|
Feb 25, 2026 |
|
글로벌 제약업계, 2026년 역풍 직면…최혜국 약가정책 영향은 제한적 (Korean-language podcast) Feb.25, 2026
|
Feb 25, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 24, 2026
|
Feb 24, 2026 |
|
Scrip's Five Must-Know Things - Feb.24, 2026
|
Feb 24, 2026 |
|
Drug Fix: ‘America First’ US FDA User Fees, Moderna’s Flu Vaccine Saga Continues
|
Feb 20, 2026 |
|
Hansa Biopharma On Clearing The Path To Kidney Transplant
|
Feb 16, 2026 |
|
ESG, Eco‑Pricing and Sustainable Packaging, with Steve Ramus
|
Feb 16, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 16, 2026
|
Feb 16, 2026 |
|
Scrip's Five Must-Know Things - Feb.16, 2026
|
Feb 16, 2026 |
|
Drug Fix: US FDA Versus Moderna And The Changing Role Of Refuse To File Actions
|
Feb 13, 2026 |
|
Preventing Lung Disease in Preterm Babies
|
Feb 09, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 9 , 2026
|
Feb 09, 2026 |
|
Scrip's Five Must-Know Things - Feb. 9, 2026
|
Feb 09, 2026 |
|
Drug Fix: US FDA Hiring Improves, But Can The Agency Avoid Oversight Erosion?
|
Feb 06, 2026 |
|
Navigating A Changing EU And US Sustainability Landscape, With Steve Ramus
|
Feb 02, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb.2, 2026
|
Feb 02, 2026 |
|
Scrip's Five Must-Know Things - Feb. 2, 2026
|
Feb 02, 2026 |
|
Drug Fix: Understanding US FDA’s CNPV Application Reviews
|
Jan 30, 2026 |
|
How Senti Bio's Programmable Cell Therapy Tackles AML's Toxicity Problem
|
Jan 27, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.26, 2026
|
Jan 26, 2026 |
|
Scrip's Five Must-Know Things - Jan. 26, 2026
|
Jan 26, 2026 |
|
Scrip JPM Podcast: Dealmaking, Regulatory And Commercial Expectations For 2026
|
Jan 23, 2026 |
|
Drug Fix: US FDA Review Speed Steady In 2025, But Will Staffing Impact In 2026?
|
Jan 23, 2026 |
|
Herantis’s ‘Elegant’ Approach In Parkinson’s
|
Jan 21, 2026 |
|
【3分で解説 #世界のファーマ】第28回 ノバルティスが警鐘 自国第一主義の弊害へ (Japanese-language podcast)
|
Jan 19, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.19, 2026
|
Jan 19, 2026 |
|
Scrip's Five Must-Know Things - Jan. 19, 2026
|
Jan 19, 2026 |
|
Drug Fix: Pazdur’s CNPV Problems, Could US FDA Release Unapproved Product Action Packages?
|
Jan 16, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.13, 2026
|
Jan 13, 2026 |
|
Scrip이 묻다: 2026년 바이오의약품 업계 전망은? 자본배분과 딜메이킹 (Korean-language podcast)
|
Jan 13, 2026 |
|
Scrip's Five Must-Know Things - Jan. 13, 2026
|
Jan 13, 2026 |
|
Drug Fix: Oncology Stalwart Richard Pazdur Leaves US FDA
|
Jan 09, 2026 |
|
Building a Nasal First line of Defense Against H5N1
|
Jan 05, 2026 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
|
Dec 22, 2025 |
|
Scrip's Five Must-Know Things - Dec. 22, 2025
|
Dec 22, 2025 |
|
“We Are On The Cusp Of A Real Revolution”: OHC Rare Disease Center Boosts Innovation
|
Dec 19, 2025 |
|
Scrip Awards Podcast, 2025 Winners
|
Dec 19, 2025 |
|
Datamonitor Healthcare Podcast: A Deep Dive into Dry AMD
|
Dec 19, 2025 |
|
Scrip M&A Podcast: PwC's Dealmaking Preview for 2026
|
Dec 16, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
|
Dec 15, 2025 |
|
Scrip's Five Must-Know Things - Dec. 15, 2025
|
Dec 15, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
|
Dec 08, 2025 |
|
Scrip's Five Must-Know Things - Dec. 8, 2025
|
Dec 08, 2025 |
|
Overcoming Drug Resistance In Oncology With Kairos Pharma's Neil Bhowmick
|
Dec 05, 2025 |
|
Drug Fix: Understanding the US FDA’s CDER Leadership Shuffle
|
Dec 05, 2025 |
|
【3分で解説 #世界のファーマ】第27回 中国バイオ企業の成長 5つのテーマ (Japanese-language podcast)
|
Dec 01, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
|
Dec 01, 2025 |
|
Scrip's Five Must-Know Things - Dec. 1, 2025
|
Dec 01, 2025 |
|
글로벌 바이오 리더들, M&A 열기 속 낙관론 확산 (Korean-language podcast)
|
Nov 28, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
|
Nov 25, 2025 |
|
Scrip's Five Must-Know Things - Nov. 25, 2025
|
Nov 25, 2025 |
|
Charles River CSO Calls For Collaboration On Non-Animal Models
|
Nov 24, 2025 |
|
Over The Counter Special: Enabling Digital Self-Care, With PAGB’s Michelle Riddalls
|
Nov 19, 2025 |
|
Digital Health Roundup: BCIs Surge Ahead, Oura Eyes BP Clearance, AI Faces New Scrutiny
|
Nov 18, 2025 |
|
Over The Counter Special: Unlocking Switch-Driven Growth, With PAGB’s Michelle Riddalls
|
Nov 18, 2025 |
|
Data-Driven Insights Reveal The Growth Engines Powering 2026 Life Sciences
|
Nov 17, 2025 |
|
EY's Arda Ural on IPOs, Financial Markets and Tarrifs
|
Nov 13, 2025 |
|
Datamonitor Healthcare Podcast: ESMO 2025
|
Nov 12, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
|
Nov 10, 2025 |
|
Scrip's Five Must-Know Things - Nov. 10, 2025
|
Nov 10, 2025 |
|
Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center
|
Nov 07, 2025 |
|
Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology
|
Nov 06, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
|
Nov 04, 2025 |
|
Scrip's Five Must-Know Things - Nov. 4, 2025
|
Nov 04, 2025 |
|
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform
|
Oct 31, 2025 |
|
Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine
|
Oct 31, 2025 |
|
Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space?
|
Oct 31, 2025 |
|
국내 바이오텍 펀딩 활성화를 위해 새로운 촉매제 필요 (Korean-language podcast)
|
Oct 31, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
|
Oct 27, 2025 |
|
Scrip's Five Must-Know Things - Oct. 27, 2025
|
Oct 27, 2025 |
|
Drug Fix: Another FDA Inspection Reorg, Industry Navigating New DTC Landscape
|
Oct 24, 2025 |
|
Winning Biotech Investors Through Strategic Partnerships and Trial Innovation
|
Oct 22, 2025 |
|
Innovating Autoimmune Treatment with In Vivo CAR-T
|
Oct 21, 2025 |
|
How Olon’s fully integrated, end-to-end ADC capabilities drive quality and scale
|
Oct 20, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
|
Oct 20, 2025 |
|
Scrip's Five Must-Know Things - Oct. 20, 2025
|
Oct 20, 2025 |
|
Drug Fix: US FDA Involved In Astra Zeneca’s Drug Pricing Deal, DOJ’s Off-Label Promotion Policy
|
Oct 17, 2025 |
|
Adalvo: Exploring European B2B Pharma’s Next Steps
|
Oct 17, 2025 |
|
Lupus Clinical Development Enters a New Era of Innovation
|
Oct 16, 2025 |
|
Essential Pharma – Following A Patient First Philosophy
|
Oct 15, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
|
Oct 14, 2025 |
|
Scrip's Five Must-Know Things - Oct. 14, 2025
|
Oct 14, 2025 |
|
Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases
|
Oct 10, 2025 |
|
Defining the Next Era of Disruption
|
Oct 07, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.7, 2025
|
Oct 07, 2025 |
|
Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes Baiao
|
Oct 06, 2025 |
|
Scrip's Five Must-Know Things - Oct. 6, 2025
|
Oct 06, 2025 |
|
Drug Fix: Government Shutdown’s Impact On US FDA, Pfizer Inks Drug Pricing Deal
|
Oct 03, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.30, 2025
|
Sep 30, 2025 |
|
Scrip's Five Must-Know Things - Sept. 30, 2025
|
Sep 30, 2025 |
|
The Generics Bulletin Podcast: Talking with AAM president and CEO John Murphy
|
Sep 26, 2025 |
|
3分で解説 #世界のファーマ】第26回 欧州の先発医薬品 米国関税15％適用へ (Japanese-language podcast) Sept.24, 2025
|
Sep 24, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.22, 2025
|
Sep 22, 2025 |
|
Scrip's Five Must-Know Things - September 22, 2025
|
Sep 22, 2025 |
|
ICROM on Innovation in HPAPI & Crystallization
|
Sep 19, 2025 |
|
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.16, 2025
|
Sep 16, 2025 |
|
Scrip's Five Must-Know Things - September 16, 2025
|
Sep 16, 2025 |
|
Drug Fix: US FDA DTC Ad Crackdown Emerges From MAHA Report
|
Sep 12, 2025 |
|
Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech
|
Sep 12, 2025 |
|
Why Local Matters: A Leadership Perspective on Community-Based Trials
|
Sep 09, 2025 |
|
From Abandonment To Opportunity In Pediatric Pharma
|
Sep 08, 2025 |
|
Scrip's Five Must-Know Things - September 5, 2025
|
Sep 08, 2025 |
|
Is It Better To Be A Sustainability ‘Shaper’ Or ‘Staller’? With PA Consulting’s Rhea Patten
|
Sep 07, 2025 |
|
Drug Fix: US FDA Drops Offit, Others From Adcomms, Releases Unapproved Product Rejection Letters
|
Sep 05, 2025 |
|
China Biopharma English-Language Podcast: China Innovative Drugs And Commercial Insurance
|
Sep 02, 2025 |
|
Scrip's Five Must-Know Things - Sept. 1, 2025
|
Sep 01, 2025 |
|
Drug Fix: US FDA Changes COVID-19 Vaccine Labeling, Reimbursement Confusion Rises
|
Aug 29, 2025 |
|
Navigating What’s Next for Global Drug Development: What Sponsors Need to Know
|
Aug 29, 2025 |
|
VC가 한발 물러설 때 바이오 기업의 대체 자금원은? (Korean-language podcast)
|
Aug 29, 2025 |
|
【3分で解説 #世界のファーマ】第25回 中国、民間保険で新薬のアクセス拡大へ
|
Aug 28, 2025 |
|
How To ‘Vibe’ With Consumers, With PA Consulting’s Rhea Patten
|
Aug 26, 2025 |
|
Scrip's Five Must-Know Things - August 25, 2025
|
Aug 25, 2025 |
|
Merck KGaA's Vision For Making Digital Health Redundant
|
Aug 22, 2025 |
|
Tevard CEO Sees Hope for HIs Daughter In His Company's tRNA Platform
|
Aug 18, 2025 |
|
Scrip's Five Must-Know Things - August 15, 2025
|
Aug 18, 2025 |
|
Scrip's Five Must-Know Things - August 8, 2025
|
Aug 12, 2025 |
|
Turning Global Ambition Into Local Reality, With Haleon’s Jo Cooper
|
Aug 11, 2025 |
|
Aurigene Oncology CEO On Biotech Valuations, CAR-Ts And Reimbursement Models
|
Aug 05, 2025 |
|
Poolbeg CEO On The Biotech’s Big Bet On Small Molecules
|
Aug 04, 2025 |
|
Scrip's Five Must-Know Things - August 4, 2025
|
Aug 04, 2025 |
|
Exploring Ex-US Markets to Reduce Risk for Your Clinical Trials
|
Aug 01, 2025 |
|
The Patient Journey: Key R&D Considerations In Rheumatoid Arthritis
|
Jul 29, 2025 |
|
Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland
|
Jul 29, 2025 |
|
Scrip's Five Must-Know Things - July 28, 2025
|
Jul 28, 2025 |
|
Drug Fix: US FDA’s New Top Drug Regulator, Sarepta’s Options After Elevidys Stand-Off
|
Jul 25, 2025 |
|
MoonLake Leaders On Its Fast-Track Vision And $500m Deal
|
Jul 23, 2025 |
|
Scrip's Five Must-Know Things - July 22, 2025
|
Jul 22, 2025 |
|
Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’
|
Jul 21, 2025 |
|
Drug Fix: CBER Director’s Political Spin On COVID-19 Vaccines And US FDA RIFs Finalized
|
Jul 18, 2025 |
|
Strategic Insights into the RNA Market
|
Jul 17, 2025 |
|
Digital Health Roundup: Autonomous Robots, Medtronic’s Surgeon School, Sleep Tech & FDA Rules
|
Jul 16, 2025 |
|
“They Are Able To Keep Their Body”: Medipost On Its Stem Cell Therapy Vision
|
Jul 16, 2025 |
|
Astellas Doubles Down on Gene Therapy Despite Industry Headwinds
|
Jul 15, 2025 |
|
Scrip's Five Must-Know Things - July 14, 2025
|
Jul 14, 2025 |
|
Seizing The GLP-1 Wellness Opportunity, With Kerry Group’s Mathieu Millette
|
Jul 14, 2025 |
|
바이오 USA: 금융 시장 스트레스, 딜메이킹 기회 창출 (Korean-language podcast)
|
Jul 11, 2025 |
|
Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines
|
Jul 09, 2025 |
|
Acuitas CSO on CRISPR Delivery Breakthrough and Innovations in Lipid Nanoparticles
|
Jul 07, 2025 |
|
Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators
|
Jul 07, 2025 |
|
How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke
|
Jul 07, 2025 |
|
Scrip's Five Must-Know Things - July 7, 2025
|
Jul 07, 2025 |
|
【3分で解説 世界のファーマ】第24回 トランプ関税 製薬大国インドへの影響 (Japanese-language podcast)
|
Jul 03, 2025 |
|
ADDF's Karen Harris: Investing in Alzheimer's Like a VC
|
Jul 02, 2025 |
|
China Biopharma English-Language Podcast: Obesity Drugs Not All About Weight Loss
|
Jul 02, 2025 |
|
Datamonitor Healthcare Podcast: ASCO 2025
|
Jun 30, 2025 |
|
Master Regulatory Hurdles and Accelerate Your Drug Development
|
Jun 30, 2025 |
|
Scrip's Five Must-Know Things - June 30, 2025
|
Jun 30, 2025 |
|
Post-BIO Podcast: Thoughts From The Frontlines
|
Jun 26, 2025 |
|
Navigating Regulatory Uncertainty: Diversity Action Plans
|
Jun 24, 2025 |
|
How to Crush Competitive Threats and Stand Out in Biotech
|
Jun 23, 2025 |
|
Scrip's Five Must-Know Things - June 23, 2025
|
Jun 23, 2025 |
|
유럽 바이오기업, 자금조달의 현주소는? (Korean-language podcast)
|
Jun 17, 2025 |
|
Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients
|
Jun 16, 2025 |
|
Unpacking EU Omnibus And Its Impact On Sustainability: With CEN Group’s Jasper Crone
|
Jun 16, 2025 |
|
Scrip's Five Must-Know Things - 16 June 2025
|
Jun 16, 2025 |
|
Drug Fix: The US and Ex-US Impact Of Most-Favored Nation Drug Pricing
|
Jun 13, 2025 |
|
Citeline Japan Awards 2025 - Entry Deadline Approaching! (Bilingual English/Japanese)
|
Jun 12, 2025 |
|
Strategies to Secure Critical Biotech Funding Amid Market Challenges
|
Jun 11, 2025 |
|
How to Survive Innovation Pressure in Today’s Biotech Landscape
|
Jun 11, 2025 |
|
Scrip's Five Must-Know Things - 9 June 2025
|
Jun 09, 2025 |
|
Drug Fix: Prasad Staying Out Of Application Reviews, US FDA Proposed Budget Cuts
|
Jun 06, 2025 |
|
A Deep Dive into Sjögren's Disease
|
Jun 06, 2025 |
|
Digital Health Roundup: Synchron Syncs With Apple, Ketryx’s AI Agents, AdvaMed’s AI RoadMap
|
Jun 04, 2025 |
|
Raj Panjabi on Flagship's Preemptive Health and Medicine Initiative
|
Jun 03, 2025 |
|
SGLT2 Inhibitors Cardiovascular and Safety Outcomes in Chronic Diseases
|
Jun 03, 2025 |
|
Plant-Based Diet Improves Outcomes in Metastatic Breast Cancer
|
Jun 03, 2025 |
|
The Generics Bulletin Podcast: The Global Generics & Biosimilars Awards 2025
|
Jun 03, 2025 |
|
Podcast: Navigating the Future of Hepatology Clinical Trials
|
Jun 02, 2025 |
|
Innovation & Integrity: The Dual Path to Success for Device Makers
|
Jun 02, 2025 |
|
Driving Innovation And Growth In France’s Self-Care Market, With Neres Luc Besançon
|
Jun 02, 2025 |
|
Scrip's Five Must-Know Things - 2 June 2025
|
Jun 02, 2025 |
|
Drug Fix: US FDA’s Private Pharma CEO Tour, HHS Changes COVID-19 Vaccine Recommendation
|
May 30, 2025 |
|
FDA in Transition: How Regulatory Shifts Are Redefining Drug Development
|
May 27, 2025 |
|
Scrip's Five Must-Know Things - 26 May 2025
|
May 26, 2025 |
|
Drug Fix: US FDA’s Big Vaccine Policy Week
|
May 23, 2025 |
|
“Powerful Yet Unexplored”: Commit Biologics Tackles The Complement System
|
May 20, 2025 |
|
제약바이오딜 투자수익률 하락…시장 불안정으로 상황 악화될 수도 (Korean-language podcast)
|
May 20, 2025 |
|
Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer
|
May 20, 2025 |
|
Scrip's Five Must-Know Things - 19 May 2025
|
May 19, 2025 |
|
China Biopharma Podcast - 14 May 2025 (Chinese language)
|
May 14, 2025 |
|
Scrip's Five Must-Know Things - 12 May 2025
|
May 12, 2025 |
|
Drug Fix: A New Director For US FDA’s Biologics Center, Guidance Production Slowdowns
|
May 09, 2025 |
|
Scrip's Five Must-Know Things - 7 May 2025
|
May 07, 2025 |
|
Everything You Wanted To Know About Real World Evidence, With IQVIA’s Volker Spitzer
|
May 06, 2025 |
|
OPPI’s Matai On India’s IPR Regime: Progress, Pain Points, Possibilities
|
May 05, 2025 |
|
Drug Fix: Vaccine Review Political Interference, Missed Deadlines A Harbinger Of US FDA Problems?
|
May 02, 2025 |
|
Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?
|
May 01, 2025 |
|
Conference Catch-Up: BIO-Europe 2025
|
May 01, 2025 |
|
Highlights from AAN 2025
|
Apr 30, 2025 |
|
Aragen CEO On Funding Cuts At NIH, Biotechs And Likely US Pharma Tariffs
|
Apr 29, 2025 |
|
Scrip's Five Must-Know Things - 28 April 2025
|
Apr 28, 2025 |
|
Drug Fix: More US FDA Departures, Makary On Combined AE Database, ‘Conditional’ Approval
|
Apr 25, 2025 |
|
Precision Medicine in Liver Treatment: The Ochre Bio Approach
|
Apr 23, 2025 |
|
Scrip's Five Must-Know Things - 21 April 2025
|
Apr 21, 2025 |
|
Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls
|
Apr 18, 2025 |
|
Scrip's Five Must-Know Things - 14 April 2025
|
Apr 14, 2025 |
|
미국 관세 롤러코스터에 제약업계는 여전히 불안 (Korean-language podcast)
|
Apr 11, 2025 |
|
Evolving The UK Consumer Health Industry, With PAGB’s Michelle Riddalls
|
Apr 07, 2025 |
|
Scrip's Five Must-Know Things - 7 April 2025
|
Apr 07, 2025 |
|
Drug Fix: Understanding The US FDA Reduction-In-Force And Its Long-Term Impact
|
Apr 04, 2025 |
|
CEO Nicolas Poirier on OSE Immunotherapeutics Latest IL-7 Data
|
Apr 03, 2025 |
|
Digital Health Roundup: Intuitive CEO Exec Chat, Patient Monitoring, Exer Labs Woes, Roche New NGS Prototype
|
Apr 02, 2025 |
|
Scrip's Five Must-Know Things - 31 March 2025
|
Mar 31, 2025 |
|
Drug Fix: Understanding The Impact Of The Latest HHS Layoffs On The US FDA
|
Mar 28, 2025 |
|
Innovative Oncology, A Conversation with iOnctura
|
Mar 28, 2025 |
|
Podcast: Heranova CMO Advocates For Endometriosis Awareness: “Pain Is Not Normal”
|
Mar 26, 2025 |
|
What To Expect From The 61st AESGP Annual Meeting, With AESGP’s Jurate Švarcaite
|
Mar 24, 2025 |
|
Scrip's Five Must-Know Things - 24 March 2025
|
Mar 24, 2025 |
|
Drug Fix: US FDA Productivity Complaints Emerge, Internal Return To Office Headaches
|
Mar 21, 2025 |
|
Scrip's Five Must-Know Things - 17 March 2025
|
Mar 17, 2025 |
|
Drug Fix: Buyouts, Departures and Other US FDA Chaos
|
Mar 14, 2025 |
|
The Generics Bulletin Podcast: Stelara Biosimilar Launches In The US
|
Mar 11, 2025 |
|
Vaccines, Viruses & Variants: The State of COVID-19 & Flu in 2025
|
Mar 11, 2025 |
|
Scrip M&A Podcast: Looking at M&A activity as Q1 2025 nears a close.
|
Mar 11, 2025 |
|
Women’s Health Innovation And Beyond, With Maxwellia’s Anna Maxwell
|
Mar 10, 2025 |
|
Scrip's Five Must-Know Things - 10 March 2025
|
Mar 10, 2025 |
|
Drug Fix: What We Learned From US FDA Commissioner Nominee Makary’s Confirmation Hearing?
|
Mar 07, 2025 |
|
Grove AI and Grace, An Agentic AI For Clinical Trial Engagement
|
Mar 07, 2025 |
|
【3分で解説 世界のファーマ】第23回 トランプ関税 製薬への影響は (Japanese-language podcast)
|
Mar 07, 2025 |
|
트럼프의 관세 인상에 대한 엇갈린 반응 (Korean-language podcast)
|
Mar 06, 2025 |
|
The Challenge Of Innovating In A Changing OTC Industry With AdverCheck’s James Walmsley
|
Mar 03, 2025 |
|
Scrip's Five Must-Know Things - 3 March 2025
|
Mar 03, 2025 |
|
Drug Fix: Laid Off US FDA Staff Called Back, Vaccine Adcomm Cancelled, Lilly’s Manufacturing Push
|
Feb 28, 2025 |
|
Scrip's Five Must-Know Things - 25 February 2025
|
Feb 25, 2025 |
|
Why OTC Firms Should Care About Rx Advertising, With AdverCheck’s James Walmsley
|
Feb 24, 2025 |
|
Drug Fix: Understanding the US FDA Layoffs And Their Impact On Industry
|
Feb 21, 2025 |
|
Scrip's Five Must-Know Things - 18 February 2025
|
Feb 18, 2025 |
|
Drug Fix: RFK’s First Actions, Pitch To Extend Current US FDA User Fee Agreement, More Trump Impacts
|
Feb 14, 2025 |
|
Podcast: JPM Tracked and Unpacked
|
Feb 13, 2025 |
|
Scrip이 묻다... 2025년 제약바이오 산업의 미래는? 세계 정치 변화의 영향 (Korean-language podcast)
|
Feb 12, 2025 |
|
Getting Creative In Consumer Health, With All Creative’s Beverley Law
|
Feb 10, 2025 |
|
Scrip's Five Must-Know Things - 10 February 2025
|
Feb 10, 2025 |
|
Drug Fix: Kennedy’s Assurances To Gain HHS Nod, US FDA Coms Freeze Continues Thawing
|
Feb 07, 2025 |
|
Harness Therapeutics CEO Talks Somatic Expansion for Neurodegeneration
|
Feb 03, 2025 |
|
Scrip's Five Must-Know Things
|
Feb 03, 2025 |
|
Datamonitor Healthcare Podcast: Epidemiology in the Age of Real World Data and AI
|
Jan 31, 2025 |
|
Drug Fix: President Trump’s Policies Begin Changing The US FDA, Kennedy’s Hill Hearings
|
Jan 31, 2025 |
|
Scrip's Five Must-Know Things - 27 January 2025
|
Jan 27, 2025 |
|
Drug Fix: Concerns and Questions As Trump Administration Takes Control Of US FDA
|
Jan 24, 2025 |
|
Fauna Bio: Gleaning Therapeutic Insights From Animals
|
Jan 20, 2025 |
|
Scrip's Five Must-Know Things - 20 January 2025
|
Jan 20, 2025 |
|
Drug Fix: US FDA And Trump’s Reforms, CDER Director Parting Comments, 2024 Approval Trends
|
Jan 17, 2025 |
|
A “Game Changer” For The High-Risk MDS Patient Population
|
Jan 17, 2025 |
|
Scrip's Five Must-Know Things - 14 January 2025
|
Jan 14, 2025 |
|
Drug Fix: CDER Director Retires, US FDA Guidance ‘Blizzard,’ Rare Pediatric Disease Program Hangs On
|
Jan 10, 2025 |
|
2025년 JP모건 헬스케어 컨퍼런스의 주요 주제는? (Korean-language podcast)
|
Jan 09, 2025 |
|
Pre-JPM Biotech Dealmaking Roundtable
|
Jan 07, 2025 |
|
Digital Health Roundup: 2025 Will See More AI/GenAI Adoption In Medtech, FDA’s Digital Health Push
|
Jan 06, 2025 |
|
The Future of Immunotherapy
|
Jan 06, 2025 |
|
An Insight into NASH
|
Dec 31, 2024 |
|
올해의 Top 5 글로벌 제약 뉴스 (Korean language podcast) - 27 December 2024
|
Dec 27, 2024 |
|
Scrip's Five Must-Know Things - 23 December 2024
|
Dec 23, 2024 |
|
The Future Of eClinical Technology
|
Dec 19, 2024 |
|
The Generics Bulletin Podcast: Highlights Of 2024
|
Dec 16, 2024 |
|
Five Must-Know Things - 16 December 2024
|
Dec 16, 2024 |
|
The Role of Site Networks & Why They Matter
|
Dec 10, 2024 |
|
Datamonitor Healthcare Podcast: Psychedelic Symposium at the University of Wisconsin-Madison
|
Dec 10, 2024 |
|
Scrip's Five Must-Know Things - 10 December 2024
|
Dec 10, 2024 |
|
Arialys Therapeutics: Treating Autoimmune Neuropsychiatric Diseases
|
Dec 09, 2024 |
|
Drug Fix: COVID-19 Vaccine EUAs In Danger, DOGE And US FDA, New 340B Rebate Pricing Models
|
Dec 06, 2024 |
|
November 2024 Datamonitor Healthcare Podcast: Bispecific Antibodies in Oncology
|
Dec 05, 2024 |
|
Treating Rare Diseases With tRNA
|
Dec 04, 2024 |
|
Conference Catch-Up: BIO-Europe 2024
|
Dec 03, 2024 |
|
Scrip's Five Must-Know Things - 2 December 2024
|
Dec 02, 2024 |
|
Scrip Awards Podcast, Ep2: 2024 Awards Preview & Verona Pharma Interview
|
Nov 28, 2024 |
|
Scrip's Five Must-Know Things - 25 November 2024
|
Nov 22, 2024 |
|
Drug Fix: Trump’s Potential Impact On FDA User Fees, Dr. Oz’s Potential Impact On CMS
|
Nov 22, 2024 |
|
Scrip's Five Must-Know Things - 18 November 2024
|
Nov 18, 2024 |
|
Drug Fix: Trump Picks Robert F. Kennedy Jr. To Lead HHS, How Could He Disrupt FDA?
|
Nov 15, 2024 |
|
Scrip M&A Podcast: Why Did Biopharma M&A Metrics Decline During Q2 And Q3
|
Nov 14, 2024 |
|
Using AI To Predict Our Immune Responses
|
Nov 11, 2024 |
|
Scrip's Five Must-Know Things - 11 November 2024
|
Nov 11, 2024 |
|
Conference Catch-Up: Navigating the Evolving CDMO Landscape
|
Nov 10, 2024 |
|
Drug Fix: How Will Trump’s Second Term Impact The US FDA?
|
Nov 08, 2024 |
|
Digital Health Roundup: GE HealthCare On AI At HLTH; EU AI Act, Click Therapeutics
|
Nov 07, 2024 |
|
Scrip's Five Must-Know Things - 5 November 2024
|
Nov 05, 2024 |
|
【3分で解説 世界のファーマ】第22回 AD治療、費用対効果に悩む英国 (Japanese-language podcast)
|
Oct 29, 2024 |
|
Scrip's Five Must-Know Things - 28 October 2024
|
Oct 28, 2024 |
|
Conference Catch-Up: The Rise of Digital Therapeutics (Part 2)
|
Oct 26, 2024 |
|
October 2024 Datamonitor Healthcare Podcast: Insights from ESMO
|
Oct 21, 2024 |
|
Scrip's Five Must-Know Things - 21 October 2024
|
Oct 21, 2024 |
|
Drug Fix: SubQ Drugs And Price Negotiations, GLP-1s In Court, US FDA Approach To Black Box AI
|
Oct 18, 2024 |
|
빅파마가 직면한 세포유전자 치료제 시장의 현실 (Korean-language podcast)
|
Oct 17, 2024 |
|
China Biopharma Podcast - 16 October 2024 (Chinese language)
|
Oct 16, 2024 |
|
Scrip's Five Must-Know Things - 15 October 2024
|
Oct 15, 2024 |
|
Drug Fix: Inside Medicare Price Negotiations, New US FDA Vaccine Pathway
|
Oct 11, 2024 |
|
Q&A Session on Psoriasis in Pediatric Patients with Dr. Valerie Welch
|
Oct 11, 2024 |
|
COPD Treatment Strategies: Q&A with Dr. Kenneth Chinsky
|
Oct 11, 2024 |
|
Noticing Neffy – A ‘Transformative Treatment’ For Type 1 Allergies
|
Oct 08, 2024 |
|
Alpha-Synuclein Testing Comes of Age
|
Oct 04, 2024 |
|
Q&A Session: PIK3CA Mutations and Breast Cancer
|
Oct 03, 2024 |
|
Conference Catch-Up: LSX World Congress USA 2024
|
Oct 02, 2024 |
|
The Future Of Drug R&D Is Self-Driving
|
Sep 30, 2024 |
|
Drug Fix: Pfizer Pulls Sickle Cell Drug, ODAC Calls Back Approved Products, New AAM CEO
|
Sep 27, 2024 |
|
Challenges in the Development and Manufacturing of ADCs
|
Sep 24, 2024 |
|
September 2024 Datamonitor Healthcare Podcast: Radiopharmaceutical Usage is Heating Up
|
Sep 19, 2024 |
|
Health-Related Quality of Life Considerations In Clinical Trials
|
Sep 16, 2024 |
|
Over the Counter: Data Tech CEO On Digital Tools Driving Faster, More Sustainable Personal Care
|
Sep 13, 2024 |
|
Drug Fix: US FDA Worries About Celebs Endorsing Drugs, Post-Chevron Lawsuits Emerging
|
Sep 13, 2024 |
|
September 2024 Datamonitor Healthcare Podcast: Diving into the TME
|
Sep 13, 2024 |
|
The Generics Bulletin Podcast: Recent And Upcoming Industry Events
|
Sep 12, 2024 |
|
【3分で解説 世界のファーマ】第21回 中国企業 日本で続々治験開始へ (Japanese-language podcast)
|
Sep 10, 2024 |
|
J&J, '차별화된' 비만 자산에 관심있어 (Korean-language podcast)
|
Sep 09, 2024 |
|
Scrip's Five Must-Know Things - 9 September 2024
|
Sep 09, 2024 |
|
Drug Fix: Pediatric Rare Disease PRV Deadline Approaches, Potential Makena Compounding Ban
|
Sep 06, 2024 |
|
Scrip's Five Must-Know Things - 2 September 2024
|
Sep 02, 2024 |
|
Drug Fix: New US FDA Developments In AI Regulation
|
Aug 30, 2024 |
|
Digital Health Roundup: Digital Therapeutics Navigate GLP-1, Gaming; DHCoE On AI; Hello Heart
|
Aug 29, 2024 |
|
Exploring The Postbiotic Opportunity In Consumer Health, With Kerry’s Sonja Nodland
|
Aug 27, 2024 |
|
Scrip's Five Must-Know Things - 26 August 2024
|
Aug 26, 2024 |
|
August 2024 Datamonitor Healthcare Podcast: The Colorful Landscape of Therapeutic Psychedelics
|
Aug 22, 2024 |
|
Bioprinting – An Innovative Tool That Is Revolutionizing Drug Discovery
|
Aug 19, 2024 |
|
Scrip's Five Must-Know Things - 19 August 2024
|
Aug 19, 2024 |
|
Drug Fix: What We Learned From The First Batch Of Medicare Negotiated Drug Prices
|
Aug 16, 2024 |
|
【3分で解説 世界のファーマ】第20回 欧州心臓病学会 注目の新薬候補は (Japanese-language podcast)
|
Aug 15, 2024 |
|
Sustainable By Design: Thermo Fisher's Meron Mathias On ESG Compliance And The Competitive Edge
|
Aug 14, 2024 |
|
Scrip's Five Must-Know Things - 13 August 2024
|
Aug 13, 2024 |
|
Why Purpose Is Key To Driving CHC Growth, With Haleon’s Bas Vorsteveld
|
Aug 12, 2024 |
|
Drug Fix: Clinical Trial Diversity, Off-Label Standard Of Care Issues, In-Person US FDA Adcomms
|
Aug 09, 2024 |
|
Type 2 Diabetes and SGLT2 Inhibitors Q&A
|
Aug 09, 2024 |
|
비만치료제, 2024년 상반기 대형주를 지배하다 (Korean-language podcast)
|
Aug 07, 2024 |
|
Scrip's Five Must-Know Things - 5 August 2024
|
Aug 05, 2024 |
|
Drug Fix: August User Fee Goals, Oncology Trial Design Issues, EMA Review Changes
|
Aug 02, 2024 |
|
China Biotech Podcast - 2 August 2024 (Chinese language)
|
Aug 02, 2024 |
|
July 2024 Datamonitor Healthcare Podcast: The Future of Biologics in COPD
|
Jul 31, 2024 |
|
Q&A Session on the Treatment of Multiple Myeloma
|
Jul 29, 2024 |
|
How To Make An Impact With Your OTC Brand, With PA Consulting’s Rhea Patten
|
Jul 29, 2024 |
|
Scrip's Five Must-Know Things - 29 July 2024
|
Jul 29, 2024 |
|
Drug Fix: US FDA Device Director Retires, PBM Execs On Capitol Hill, Voucher Program Renewal Push
|
Jul 26, 2024 |
|
The Exciting Future of Heart Failure Management
|
Jul 26, 2024 |
|
Early Detection Key in COPD Management (Q&A with Brittany Little, NP)
|
Jul 26, 2024 |
|
Digital Health Roundup: Brain Talk; Medtronic’s Digital Tech Report OR; UK Guidance
|
Jul 23, 2024 |
|
Scrip's Five Must-Know Things - 22 July 2024
|
Jul 22, 2024 |
|
Medtech Connect 16: AI For Cross Border Regulation
|
Jul 20, 2024 |
|
Drug Fix Special: Why The US Approves Most New Drugs Before The EU
|
Jul 19, 2024 |
|
국내 AI 신약개발, 선진국과 격차 줄이려면? (Korean-language podcast)
|
Jul 16, 2024 |
|
The Importance of Exploring Genetic Potential
|
Jul 16, 2024 |
|
Scrip's Five Must-Know Things - 16 July 2024
|
Jul 16, 2024 |
|
EPR Consultant Urges Producers To Start Collecting Packaging Data
|
Jul 12, 2024 |
|
Improving Communication: The Relationship Between Biotech And Biopharma
|
Jul 10, 2024 |
|
【3分で解説 世界のファーマ】第19回 FDA「密な面談」を企業に呼び掛け (Japanese-language podcast)
|
Jul 09, 2024 |
|
Scrip's Five Must-Know Things - 8 July 2024
|
Jul 08, 2024 |
|
Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead
|
Jul 05, 2024 |
|
Non-Invasive Solutions: Exploring The Role Of Breath Biopsies In Early Detection
|
Jul 05, 2024 |
|
In Vivo Podcast Episode with Stefan Woxström
|
Jul 02, 2024 |
|
How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz
|
Jul 01, 2024 |
|
Scrip's Five Must-Know Things - 1 July 2024
|
Jul 01, 2024 |
|
Drug Fix: What’s In And Out Of US FDA’s Diversity Action Plan Guidance, AI Guidance Also Coming
|
Jun 28, 2024 |
|
China Biotech Podcast - 26 June 2024 (Chinese language)
|
Jun 26, 2024 |
|
Scrip's Five Must-Know Things - 24 June 2024
|
Jun 24, 2024 |
|
Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB
|
Jun 21, 2024 |
|
The Power Of Herbs For Women’s Wellness, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley
|
Jun 17, 2024 |
|
Scrip's Five Must-Know Things - 17 June 2024
|
Jun 17, 2024 |
|
Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond
|
Jun 14, 2024 |
|
June 2024 Datamonitor Healthcare Podcast: ASCO 2024
|
Jun 14, 2024 |
|
China Biotech Podcast - 14 June 2024 (Bilingual Chinese/English)
|
Jun 14, 2024 |
|
ASCO 결산: 암 연구의 미래는? (Korean-language podcast)
|
Jun 13, 2024 |
|
Scrip's Five Must-Know Things - 10 June 2024
|
Jun 10, 2024 |
|
The Generics Bulletin Podcast: Teva, Sandoz, Sawai and US Orange Book patents
|
Jun 07, 2024 |
|
China Biotech Podcast - 5 June 2024 (Chinese language)
|
Jun 05, 2024 |
|
JB CEO On CDMO Growth, Red Sea Crisis And More
|
Jun 04, 2024 |
|
Scrip's Five Must-Know Things - 3 June 2024
|
Jun 03, 2024 |
|
The Scrip Awards Podcast. Episode 1: Genmab: The Ongoing Evolution Of Europe’s Antibody Powerhouse
|
May 31, 2024 |
|
How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone
|
May 31, 2024 |
|
Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions
|
May 31, 2024 |
|
'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovation
|
May 29, 2024 |
|
China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen
|
May 28, 2024 |
|
Citeline Japan Awards 2024 - Enter Now! (Bilingual English/Japanese)
|
May 28, 2024 |
|
Scrip's Five Must-Know Things - 27 May 2024
|
May 27, 2024 |
|
Drug Fix: Novel Clinical Trial Reg Problems, NIH Drug ‘Access Plans’, Good Ole Days Of Woodcock
|
May 24, 2024 |
|
【3分で解説 世界のファーマ】第18回 GLP-1を超える肥満治療薬のカギとは？(Japanese-language podcast)
|
May 23, 2024 |
|
Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing
|
May 22, 2024 |
|
Leading PRO Discusses Plans For Administering State EPR Programs
|
May 21, 2024 |
|
개발 VS 딜메이킹: 블록버스터 신약을 확보하는 방법 (Korean-language podcast)
|
May 21, 2024 |
|
How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane
|
May 20, 2024 |
|
Scrip's Five Must-Know Things - 20 May 2024
|
May 20, 2024 |
|
Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation
|
May 17, 2024 |
|
May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma
|
May 17, 2024 |
|
China Biotech Podcast - 15 May 2024 (Chinese- and English-Language)
|
May 15, 2024 |
|
Scrip's Five Must-Know Things - 13 May 2024
|
May 13, 2024 |
|
Episode 15: Digital Trust
|
May 09, 2024 |
|
Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta
|
May 07, 2024 |
|
Scrip's Five Must-Know Things - 7 May 2024
|
May 07, 2024 |
|
Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review
|
May 03, 2024 |
|
Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch
|
Apr 30, 2024 |
|
April Datamonitor Podcast 2024: AAN coverage
|
Apr 30, 2024 |
|
Scrip's Five Must-Know Things - 30 April 2024
|
Apr 30, 2024 |
|
2024 Global Generics & Biosimilars Awards
|
Apr 29, 2024 |
|
Podcast: Facilitating Patient Monitoring in CAR-T Development
|
Apr 29, 2024 |
|
Drug Fix: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics
|
Apr 26, 2024 |
|
Dr. Xue Discusses Treatment Guideline Updates for COPD in This Q&A Session
|
Apr 26, 2024 |
|
China Biotech Podcast - 26 April 2024 (Chinese and English Language)
|
Apr 26, 2024 |
|
Future Governance & Oversight of the EU Medtech Regulatory System
|
Apr 24, 2024 |
|
Citeline - Cerba Research Podcast V2
|
Apr 23, 2024 |
|
Scrip M&A Podcast: Are Buyers Coming For Viking, Verona, Altimmune, Xenon And Crinetics
|
Apr 23, 2024 |
|
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
|
Apr 22, 2024 |
|
Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo’s Anita Nahal
|
Apr 22, 2024 |
|
Scrip's Five Must-Know Things - 22 April 2024
|
Apr 22, 2024 |
|
Drug Fix: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
|
Apr 19, 2024 |
|
Next-Generation Diagnostics: "Breathomics" From Imspex
|
Apr 19, 2024 |
|
Ratio Therapeutics On BMS Buy-In, Radiopharma R&D Trends, AI And Assets
|
Apr 16, 2024 |
|
China Biotech Podcast (Chinese- and English-language) - April 2024
|
Apr 15, 2024 |
|
Scrip's Five Must-Know Things - 15 April 2024
|
Apr 15, 2024 |
|
Drug Fix: US FDA Adcomm Open Public Hearings, Clinical Trial Diversity Plans, Stealth’s Elamipretide
|
Apr 12, 2024 |
|
In Conversation With 2024 In Vivo Rising Leader, Hanadie Yousef
|
Apr 09, 2024 |
|
Scrip's Five Must-Know Things - 8 April 2024
|
Apr 08, 2024 |
|
Drug Fix: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA
|
Apr 05, 2024 |
|
Medtech Connect Episode 14: Live From HIMSS 2024
|
Apr 03, 2024 |
|
피노바이오, 국내 ADC 생태계 발전에 기여할 것 (Korean-language podcast)
|
Apr 02, 2024 |
|
Scrip's Five Must-Know Things - 1 April 2024
|
Apr 01, 2024 |
|
Analysing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
|
Mar 28, 2024 |
|
March Datamonitor Podcast 2024: The US Inflation Reduction Act
|
Mar 27, 2024 |
|
Scrip's Five Must-Know Things - 26 March 2024
|
Mar 26, 2024 |
|
Drug Fix: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC
|
Mar 22, 2024 |
|
China Biotech Podcast (Chinese language) - March 2024
|
Mar 22, 2024 |
|
Digital Health Roundup: EU’s AI Act Impact; Verily's Andrew Trister’s Vision For Personal AI Agent
|
Mar 20, 2024 |
|
Scrip's Five Must-Know Things - 18 March 2024
|
Mar 18, 2024 |
|
How AI Is Revolutionizing Personalized Wellness, With Bioniq’s Marni Allen
|
Mar 15, 2024 |
|
【3分で解説 世界のファーマ】第17回 LSDで不安症を治療 第III相開始へ (Japanese-language podcast)
|
Mar 13, 2024 |
|
"Identifying The 80% Of Undiagnosed And Misdiagnosed Patients"
|
Mar 11, 2024 |
|
Scrip's Five Must-Know Things - 11 March 2024
|
Mar 11, 2024 |
|
Drug Fix: Vanda Appeals US FDA Jet Lag Denial In Court, Mark Cuban Battles PBMs, Austere FDA Budget
|
Mar 08, 2024 |
|
Scrip이 묻다: 2024년 제약바이오업계 전망은? 치료영역의 발전 (Korean-language podcast)
|
Mar 07, 2024 |
|
Medtech Connect Episode 13: Augmented Reality In Surgery
|
Mar 07, 2024 |
|
Scrip's Five Must-Know Things - 4 March 2024
|
Mar 04, 2024 |
|
Cardio Conversations: iRhythm CEO Blackford Talks AI Arrhythmia Diagnostics
|
Mar 04, 2024 |
|
The Emerging Benefits Of ‘Beauty-From-Within,’ Featuring Kenvue’s Paul LaTerra
|
Mar 01, 2024 |
|
February Datamonitor Podcast: 2024 Clinical Outlook
|
Feb 28, 2024 |
|
NodThera On The Role Of The Brain In Driving Chronic Disease
|
Feb 28, 2024 |
|
Scrip's Five Must-Know Things - 26 February 2024
|
Feb 26, 2024 |
|
Drug Fix: US FDA And Psychedelic Drugs, Aduhelm Clinical Trial Data, Adcomm Candidates
|
Feb 23, 2024 |
|
AESGP’s 60th Birthday Celebrations In 2024 Including Annual Meeting, With Jurate Švarcaite
|
Feb 20, 2024 |
|
Drug Fix: Price Negotiation Suit Tossed, Drug Shortage Probe, FDA-Approved Marijuana
|
Feb 16, 2024 |
|
Drug Fix: State Of The Generic Industry, US FDA Under Second Trump Term, Inspections And Shortages
|
Feb 09, 2024 |
|
China Biotech Podcast (Chinese and English Language) - February 2024
|
Feb 08, 2024 |
|
혁신 육성 전략에 기반한 한국의 제약바이오 강국 야망 (Korean-language podcast)
|
Feb 07, 2024 |
|
Trio Of Diagnostics Execs Weigh In On Upcoming Challenges
|
Feb 06, 2024 |
|
China Biotech Podcast - Interview With BeiGene Co-Founder Xiaodong Wang
|
Feb 06, 2024 |
|
Title: The Promise Of AI For Consumer Health, Pt 2, With The Exponential Club’s Nick Tate
|
Feb 05, 2024 |
|
Scrip's Five Must-Know Things - 5 February 2024
|
Feb 05, 2024 |
|
Digital Health Roundup: CES Biggest Hits; Apple Versus Masimo; Insulet Recalls Diabetes App
|
Jan 30, 2024 |
|
Automating Cell Therapy Manufacturing: Cellular Origins' CEO Talks Robotics
|
Jan 29, 2024 |
|
Scrip's Five Must-Know Things - 29 January 2024
|
Jan 29, 2024 |
|
Medtech Connect Episode 12: Apple’s Patent Infringement Cases
|
Jan 26, 2024 |
|
Drug Fix: Janet Woodcock And The US FDA’s G.O.A.T., Puberty Blockers Meeting, CAR-T Safety
|
Jan 26, 2024 |
|
Q&A Session on Treatment of LBCL With Oncologist Donald Fleming, MD
|
Jan 22, 2024 |
|
The Promise Of AI For Consumer Health, Pt 1, With The Exponential Club’s Nick Tate
|
Jan 22, 2024 |
|
Drug Fix: US FDA Adcomm Schedule, CMS And Drug Importation, Missed User Fee Goals
|
Jan 19, 2024 |
|
China Biotech Podcast - Major Takeaways From JPM (January 2024 - Chinese-Language)
|
Jan 19, 2024 |
|
【3分で解説 世界のファーマ】第16回 JPモルガンで見えた2024年の製薬業界 (Japanese-language podcast)
|
Jan 19, 2024 |
|
Scrip's Five Must-Know Things - 15 January 2024
|
Jan 15, 2024 |
|
Pennine Health Talks Sustainability Compliance and ESG Initiatives
|
Jan 12, 2024 |
|
Drug Fix: Project Orbis For Gene Therapy, US FDA Leaders’ 2024 Predictions, FDA and AI
|
Jan 12, 2024 |
|
Building A Biotech: Exploring ILC’s Hybrid Interferon Platform
|
Jan 11, 2024 |
|
전 세계 비만 치료제 임상시험 건 수, 미국이 가장 높아…한국은 9위 (Korean-language podcast)
|
Jan 11, 2024 |
|
Scrip's Five Must-Know Things - 10 January 2024
|
Jan 10, 2024 |
|
Podcast: Current trends in the biotech landscape with Chris Smyth, President, ICON Biotech Solutions
|
Jan 09, 2024 |
|
China Biotech Podcast - January 2024 (Chinese-language)
|
Jan 09, 2024 |
|
Cardio Conversations: AVS Cracks Calcium With Novel Pressure Wave Balloon
|
Jan 05, 2024 |
|
Drug Fix: Looking Back And Looking Ahead: Key US and EU Legislation
|
Jan 05, 2024 |
|
Unlock the Future of Cancer Detection with Dr Charles P. Vega, MD, FAAFP: Listen Now!
|
Jan 03, 2024 |
|
The Challenges of Rare Neurological Disease Drug Development
|
Dec 22, 2023 |
|
【3分で解説 世界のファーマ】第15回 治験に被験者の「多様性」を 米国の課題 (Japanese-language podcast)
|
Dec 22, 2023 |
|
Medtech Connect Episode 11: A Look Back At 2023
|
Dec 20, 2023 |
|
Biopharma’s Must-Know 2023-4 Catalysts
|
Dec 20, 2023 |
|
Scrip’s Five Must-Know Things – 19 December 2023
|
Dec 19, 2023 |
|
Drug Fix: Taking A Look Back, And Forward, With US FDA’s Project Orbis
|
Dec 15, 2023 |
|
China Biotech Podcast - December 2023 (Chinese-language)
|
Dec 14, 2023 |
|
Scrip’s Five Must-Know Things – 11 December 2023
|
Dec 11, 2023 |
|
Over the Counter 7 Dec 2023: IFRA On Potential Impact Of EU's CLP Revision
|
Dec 07, 2023 |
|
제약업계의 생성형AI 적용 성공의 열쇠는? (Korean-language podcast)
|
Dec 05, 2023 |
|
Scrip's Five Must-Know Things - 4 December 2023
|
Dec 04, 2023 |
|
Drug Fix: CAR-T Malignancy Reports, Background Music In DTC Ads, New No. 2 At US FDA
|
Dec 01, 2023 |
|
RNA And Kidneys And Diagnostics RNA, Oh My – Discussing Verici DX’s Differentiated Product Offering
|
Nov 27, 2023 |
|
Scrip’s Five Must-Know Things – 27 November 2023
|
Nov 27, 2023 |
|
Trends In Epidemiology
|
Nov 23, 2023 |
|
Scrip Lifetime Achievement Award 2023: Jeremy Levin’s Acceptance Speech
|
Nov 22, 2023 |
|
China Biotech Podcast (Chinese language) - November 2023
|
Nov 21, 2023 |
|
Discussing The Potentials Of And Challenges For Digital Therapeutics
|
Nov 21, 2023 |
|
Digital Health Roundup: Black Friday Hits – Digital Twins, Biowearables, Robotics, Cardiology
|
Nov 21, 2023 |
|
Scrip’s Five Must-Know Things – 20 November 2023
|
Nov 20, 2023 |
|
Drug Fix: Janet Woodcock retiring, Accelerated Approval Reform, US FDA Meeting Recording Policy
|
Nov 17, 2023 |